Related Experiment Videos

Intra-cellular electrolyte changes and levels of endogenous digoxin-like substance within the plasma in patients with

Z Q Liu1, A Q Ma, L Zhang

  • 1Department of Cardiovascular Medicine, First Teaching Hospital of Xi'an Medical University, P.R. China.

Insights

Elevated endogenous digoxin-like substance in heart failure patients correlates with electrolyte imbalances and reduced Na/K-ATPase activity. Non-digitalis therapy improved these markers, suggesting a role for this substance in congestive heart failure pathophysiology.

Area of Science:

  • Cardiology
  • Biochemistry
  • Cellular Physiology

Background:

  • Chronic congestive heart failure (CHF) is associated with complex physiological alterations.
  • Electrolyte balance and membrane transport are critical for cardiac function.

Purpose of the Study:

  • To investigate the relationship between intracellular electrolytes, endogenous digoxin-like substance (EDLS), and Na/K-ATPase activity in CHF patients.
  • To explore the potential role of EDLS in CHF-related electrolyte disturbances.

Main Methods:

  • Analysis of intracellular potassium, sodium, calcium, and magnesium in lymphocytes and erythrocytes from 50 CHF patients and 39 controls.
  • Measurement of plasma EDLS levels and red blood cell membrane Na/K-ATPase activity.
  • Correlation analysis between electrolyte levels, EDLS, and Na/K-ATPase activity.

Main Results:

  • CHF patients exhibited decreased intracellular potassium and magnesium, and increased intracellular sodium and calcium.
  • Plasma EDLS levels were significantly elevated in CHF patients compared to controls.
  • Na/K-ATPase activity was significantly lower in CHF patients, correlating with higher EDLS levels.

Conclusions:

  • Endogenous digoxin-like substance may contribute to the intracellular electrolyte imbalance observed in congestive heart failure.
  • Therapeutic interventions not involving digitalis led to recovery of electrolyte balance and improved Na/K-ATPase activity, with decreased EDLS levels.
  • Digoxin therapy could potentially worsen intracellular potassium loss in CHF patients.

Related Concept Videos